iMANY Helps Global Pharmaceutical Companies Successfully Manage the Operational Impact of the 340B Drug Discount Program
PHILADELPHIA, PA — (Marketwire) — 11/08/11 — , the leading provider of , announced today that three of the world-s largest pharmaceutical companies have implemented the iMANY® 340B Compliance Manager to facilitate accurate pricing management calculations in line with the guidelines specified in the 340B Integrity Provision of the Affordable Care Act.The 340B Drug Pricing Program requires pharmaceutical manufacturers to provide outpatient medications at a significant price discount to fe